Globus Medical Files 8-K on Operations & Financial Condition
Ticker: GMED · Form: 8-K · Filed: Jan 10, 2024 · CIK: 1237831
| Field | Detail |
|---|---|
| Company | Globus Medical Inc (GMED) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-K, corporate-update
TL;DR
**GMED just dropped an 8-K on its financials, get ready for potential market moves.**
AI Summary
Globus Medical, Inc. filed an 8-K on January 10, 2024, to report on its results of operations and financial condition. This filing indicates that the company is providing an update on its financial performance, which is crucial for investors to understand the company's health and future prospects. For shareholders, this matters because it offers transparency into how the company is performing, potentially influencing stock price based on whether the results meet or exceed expectations.
Why It Matters
This filing signals that Globus Medical is updating the market on its financial health, which can directly impact investor confidence and stock valuation.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate adverse events or significant new risks.
Analyst Insight
A smart investor would review the full financial statements and results of operations once they are available to understand the company's performance and adjust their investment thesis accordingly.
Key Numbers
- $0.001 — Par value per share (Represents the nominal value of each Class A Common Stock share for Globus Medical, Inc.)
Key Players & Entities
- GLOBUS MEDICAL, INC. (company) — the registrant filing the 8-K
- January 10, 2024 (date) — date of earliest event reported and filing date
- New York Stock Exchange (company) — exchange where GMED Class A Common Stock is registered
- GMED (company) — trading symbol for Globus Medical, Inc.
- $0.001 (dollar_amount) — par value per share of Class A Common Stock
FAQ
What is the purpose of this 8-K filing by Globus Medical, Inc.?
The purpose of this 8-K filing, dated January 10, 2024, is to report on the 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' of Globus Medical, Inc., as indicated in the 'ITEM INFORMATION' section.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is January 10, 2024, as stated under 'Date of Report (Date of earliest event reported): January 10, 2024'.
What is the trading symbol and the exchange where Globus Medical, Inc.'s stock is registered?
Globus Medical, Inc.'s Class A Common Stock has the trading symbol 'GMED' and is registered on the 'New York Stock Exchange', as listed under 'Securities registered pursuant to Section 12(b) of the Act'.
What is the state of incorporation for Globus Medical, Inc.?
Globus Medical, Inc. is incorporated in 'DELAWARE', as specified in the filing under 'State or other jurisdiction of incorporation'.
What is the business address and phone number of Globus Medical, Inc.?
The business address for Globus Medical, Inc. is '2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA 19403-5214' and their telephone number is '(610) 930-1800', as provided in the filing.
Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-01-10 16:35:05
Filing Documents
- gmed-20240110x8k.htm (8-K) — 71KB
- gmed-20240110xex99_1.htm (EX-99.1) — 19KB
- 0001562762-24-000006.txt ( ) — 207KB
- gmed-20240110.xsd (EX-101.SCH) — 2KB
- gmed-20240110_lab.xml (EX-101.LAB) — 12KB
- gmed-20240110_pre.xml (EX-101.PRE) — 11KB
- gmed-20240110x8k_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 10, 2024, we issued a press release reporting our preliminary unaudited net sales results for the three-month period and fiscal year ended December 31, 2023. The press release also included preliminary guidance for certain financial measures for the 2024 fiscal year. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be "furnished" and shall not be deemed to be "filed" with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated January 10, 2024 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLOBUS MEDICAL, INC. (Registrant) Dated: January 10, 2024 /s/ KEITH PFEIL Keith Pfeil Chief Financial Officer Chief Accounting Officer Senior Vice President (Principal Financial Officer)